BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3238538)

  • 1. [A case of mixed connective tissue disease (MCTD) complicating pulmonary hypertension and portal hypertension].
    Sawai T; Tutikawa K; Watanabe T; Kyogoku M
    Ryumachi; 1988 Jun; 28(3):164-9. PubMed ID: 3238538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Portal and pulmonary hypertension in a patient with MCTD].
    Sekiguchi Y; Amano K; Takano Y; Saito K; Itoh I; Tsuzaka K; Abe T; Takeuchi T
    Ryumachi; 1999 Aug; 39(4):657-63. PubMed ID: 10536483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study.
    Hosoda Y; Suzuki Y; Takano M; Tojo T; Homma M
    J Rheumatol; 1987 Aug; 14(4):826-30. PubMed ID: 3668989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible pulmonary hypertension in a woman with connective tissue disease].
    Jensen GG
    Ugeskr Laeger; 1992 Oct; 154(44):3065-6. PubMed ID: 1462404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vascular manifestations of mixed connective tissue disease.
    Bull TM; Fagan KA; Badesch DB
    Rheum Dis Clin North Am; 2005 Aug; 31(3):451-64, vi. PubMed ID: 16084318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of mixed connective tissue disease accompanied with idiopathic portal hypertension and pulmonary hypertension].
    Ozawa T; Nakagawa O; Hasegawa S; Honma T; Kikuchi M; Sato T; Nakano M; Arakawa M
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1799-800. PubMed ID: 2625610
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease.
    Shinohara S; Murata I; Yamada H; Sato T; Kikutani T; Inoue T; Ito K
    J Rheumatol; 1994 Sep; 21(9):1763-5. PubMed ID: 7799364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
    Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
    Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal primary pulmonary hypertension in mixed connective tissue disease.
    Eulderink F; Cats A
    Z Rheumatol; 1981; 40(1):25-9. PubMed ID: 7223079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
    Sasaki N; Kurose A; Inoue H; Sawai T
    Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular manifestations in mixed connective tissue disease in adults].
    Badui E; Robles Saavedra E; García Rubí D; Mintz Spiro G
    Arch Inst Cardiol Mex; 1984; 54(5):493-7. PubMed ID: 6240233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
    Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
    Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatal pulmonary hypertension in Sharp syndrome (M.C.T.D.) with pulmonary fibrosis].
    Remacle P; Bruart J; Henneghien C; Schreiber S
    Rev Med Brux; 1990; 11(1-2):26-30. PubMed ID: 2305135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Puerperal secondary pulmonary hypertension in a patient with mixed connective tissue disease].
    Watanabe R; Tatsumi K; Uchiyama T; Kato K; Okada O; Nagao K; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):883-7. PubMed ID: 7474571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of survival in mixed connective tissue disease (MCTD)].
    Bodolay E; Gaál J; Végh J; Soltész P; Szodoray P; Lakos G; Nemes Z; Dezsö B; Szegedi G
    Orv Hetil; 2002 Nov; 143(45):2543-8. PubMed ID: 12501560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mixed connective tissue disease].
    Kitamoto K
    Ryoikibetsu Shokogun Shirizu; 1996; (15):173-5. PubMed ID: 9047978
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease.
    Distler JH; Strapatsas T; Huscher D; Dees C; Akhmetshina A; Kiener HP; Tarner IH; Maurer B; Walder M; Michel B; Gay S; Smolen JS; Müller-Ladner U; Schett G; Distler O
    Ann Rheum Dis; 2011 Jul; 70(7):1197-202. PubMed ID: 21622771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary hypertension in connective tissue disease].
    Kasukawa R
    Ryumachi; 1991 Aug; 31(4):430-9. PubMed ID: 1948460
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of mixed connective tissue disease with pulmonary hypertension (author's transl)].
    Abe Y; Ishikawa S; Naito M; Kobayashi K; Honda M
    Kokyu To Junkan; 1978 Sep; 26(9):897-902. PubMed ID: 705062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.